Distinct phenotypes and regenerative potentials of early endothelial progenitor cells and outgrowth endothelial progenitor cells derived from umbilical cord blood
Jeffrey Reagan
Department of Orthopedic Surgery, Saint Louis University, St. Louis, MO, USA
Search for more papers by this authorTracy Foo
Department of Orthopedic Surgery, Saint Louis University, St. Louis, MO, USA
Search for more papers by this authorJohn Tracy Watson
Department of Orthopedic Surgery, Saint Louis University, St. Louis, MO, USA
Search for more papers by this authorWu Jin
Department of Orthopedic Surgery, Saint Louis University, St. Louis, MO, USA
Search for more papers by this authorBerton R Moed
Department of Orthopedic Surgery, Saint Louis University, St. Louis, MO, USA
Search for more papers by this authorCorresponding Author
Zijun Zhang
Department of Orthopedic Surgery, Saint Louis University, St. Louis, MO, USA
Department of Orthopedic Surgery, Saint Louis University, 3635 Vista Avenue, DT-7 St. Louis, MO 63110, USA.Search for more papers by this authorJeffrey Reagan
Department of Orthopedic Surgery, Saint Louis University, St. Louis, MO, USA
Search for more papers by this authorTracy Foo
Department of Orthopedic Surgery, Saint Louis University, St. Louis, MO, USA
Search for more papers by this authorJohn Tracy Watson
Department of Orthopedic Surgery, Saint Louis University, St. Louis, MO, USA
Search for more papers by this authorWu Jin
Department of Orthopedic Surgery, Saint Louis University, St. Louis, MO, USA
Search for more papers by this authorBerton R Moed
Department of Orthopedic Surgery, Saint Louis University, St. Louis, MO, USA
Search for more papers by this authorCorresponding Author
Zijun Zhang
Department of Orthopedic Surgery, Saint Louis University, St. Louis, MO, USA
Department of Orthopedic Surgery, Saint Louis University, 3635 Vista Avenue, DT-7 St. Louis, MO 63110, USA.Search for more papers by this authorAbstract
The capability of postnatal neovascularization makes circulating endothelial progenitor cells (EPCs) promising for regenerative medicine and tissue engineering. Using EPCs isolated from umbilical cord blood, this study aimed to clarify the transition of functional properties from early EPCs (e-EPCs) to outgrowth EPCs (og-EPCs) for potential applications in regenerative medicine. Mononuclear cells were collected from umbilical cord blood via density gradient centrifugation and further negatively selected by CD45. EPCs were sorted from mononuclear cells by the expression of CD34. e-EPCs (7 days of culture) and og-EPCs (3 weeks of culture) were characterized by morphology, intake of acetylated low-density lipoprotein, vessel-cord formation, cell surface phenotype and the expression of angiogenic genes. e-EPCs and og-EPCs were also compared for osteogenic differentiation under the stimulation of BMP-2. Chemotaxis by SDF-1 was compared among og-EPCs and the first- and second-day attached e-EPCs. Based on the expression of angiogenic genes, e-EPCs possessed few angiogenic properties in vitro and og-EPCs were angiogenic. e-EPCs, however, expressed significant CXCR4 and migrated toward the SDF-1 gradient. og-ECPs did not express CXCR4 and showed no response to SDF-1. During culture, gaining an angiogenic phenotype by og-EPCs is associated with the loss of homing potential. These contrast properties determine different potentials of e-EPCs and og-EPCs in regenerative medicine. Copyright © 2010 John Wiley & Sons, Ltd.
References
- Allegra A, Coppolino G, Bolignano D, et al. 2009; Endothelial progenitor cells: pathogenetic role and therapeutic perspectives. J Nephrol 22(4): 463–475.
- Asahara T, Murohara T, Sullivan A, et al. 1997; Isolation of putative progenitor endothelial cells for angiogenesis. Science 275(5302): 964–967.
- Asahara T, Masuda H, Takahashi T, et al. 1999; Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85(3): 221–228.
- Case J, Mead LE, Bessler WK, et al. 2007; Human CD34+ AC133+ VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Exp Hematol 35(7): 1109–1118.
- Das H, Abdulhameed N, Joseph M, et al. 2009; Ex vivo nanofiber expansion and genetic modification of human cord blood-derived progenitor/stem cells enhances vasculogenesis. Cell Transpl 18(3): 305–318.
- Eghbali-Fatourechi GZ, Mödder UIL, Charatcharoenwitthaya N, et al. 2007; Characterization of circulating osteoblast lineage cells in humans. Bone 40(5): 1370–1377.
- Fadini GP, Baesso I, Albiero M, et al. 2008; Technical notes on endothelial progenitor cells: ways to escape from the knowledge plateau. Atherosclerosis 197: 496–503.
- Gori F, Thomas T, Hicok KC, et al. 1999; Differentiation of human marrow stromal precursor cells: bone morphogenetic protein-2 increases OSF2/CBFA1, enhances osteoblast commitment, and inhibits late adipocyte maturation. J Bone Miner Res 14(9): 1522–1535.
- Gulati R, Jevremovic D, Peterson TE, et al. 2003; Diverse origin and function of cells with endothelial phenotype obtained from adult human blood. Circ Res 93(11): 1023–1025.
- Gulati R, Jevremovic D, Witt TA, et al. 2004; Modulation of the vascular response to injury by autologous blood-derived outgrowth endothelial cells. Am J Physiol Heart Circ Physiol 287(2): H512–517.
- Hill JM, Zalos G, Halcox JP, et al. 2003; Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348(7): 593–600.
- Hirschi KK, Ingram DA, Yoder MC. 2008; Assessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscler Thromb Vasc Biol 28(9): 1584–1595.
- Hur J, Yoon CH, Kim HS, et al. 2004; Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol 24(2): 288–293.
- Ingram DA, Mead LE, Tanaka H, et al. 2004; Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 104: 2752–2760.
- Kalka C, Masuda H, Takahashi T, et al. 2000; Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 97(7): 3422–3427.
- Kawamoto A, Gwon HC, Iwaguro H, et al. 2001; Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 103(5): 634–637.
- Kawamoto A, Tkebuchava T, Yamaguchi J, et al. 2003; Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation 107(3): 461–468.
- Kitaori T, Ito H, Schwarz EM, et al. 2009; Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model. Arthritis Rheum 60(3): 813–823.
- Kocher AA, Schuster MD, Szabolcs MJ, et al. 2001; Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7(4): 430–436.
- Madlambayan G, Rogers I. 2006; Umbilical cord-derived stem cells for tissue therapy: current and future uses. Regen Med 1: 777–787.
- Matsumoto T, Kawamoto A, Kuroda R, et al. 2006; Therapeutic potential of vasculogenesis and osteogenesis promoted by peripheral blood CD34-positive cells for functional bone healing. Am J Pathol 169: 1440–1457.
- Matsumoto T, Mifune Y, Kawamoto A, et al. 2008; Fracture-induced mobilization and incorporation of bone marrow-derived endothelial progenitor cells for bone healing. J Cell Physiol 215(1): 234–242.
- Nagano M, Yamashita T, Hamada H, et al. 2007; Identification of functional endothelial progenitor cells suitable for the treatment of ischemic tissue using human umbilical cord blood. Blood 110(1): 151–160.
- Peichev M, Naiyer AJ, Pereira D, et al. 2000; Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors. Blood 95(3): 952–958.
- Prokopi M, Pula G, Mayr U, et al. 2009; Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures. Blood 114(3): 723–732.
- Schantz JT, Chim H, Whiteman M. 2007; Cell guidance in tissue engineering: SDF-1 mediates site-directed homing of mesenchymal stem cells within three-dimensional polycaprolactone scaffolds. Tissue Eng 13(11): 2615–2624.
- Schmidt D, Asmis LM, Odermatt B, et al. 2006; Engineered living blood vessels: functional endothelia generated from human umbilical cord-derived progenitors. Ann Thorac Surg 82(4): 1465–1471.
- Schweitzer KM, Vicart P, Delouis C, et al. 1997; Characterization of a newly established human bone marrow endothelial cell line: distinct adhesive properties for hematopoietic progenitors compared with human umbilical vein endothelial cells. Lab Invest 76(1): 25–36.
- Steurer M, Kern J, Zitt M, et al. 2008; Quantification of circulating endothelial and progenitor cells: comparison of quantitative PCR and four-channel flow cytometry. BMC Res Notes 1: 71.
- Timmermans F, Van Hauwermeiren F, De Smedt M, et al. 2007; Endothelial outgrowth cells are not derived from CD133+ cells or CD45+ hematopoietic precursors. Arterioscler Thromb Vasc Biol 27(7): 1572–1579.
- Timmermans F, Plum J, Yöder MC, et al. 2009; Endothelial progenitor cells: identity defined? J Cell Mol Med 13(1): 87–102.
- Usami K, Mizuno H, Okada K, et al. 2009; Composite implantation of mesenchymal stem cells with endothelial progenitor cells enhances tissue-engineered bone formation. J Biomed Mater Res A 90(3): 730–741.
- Vodyanik MA, Thomson JA, Slukvin II. 2006; Leukosialin (CD43) defines hematopoietic progenitors in human embryonic stem cell differentiation cultures. Blood 108(6): 2095–2105.
- Walter DH, Haendeler J, Reinhold J, et al. 2005; Impaired CXCR4 signaling contributes to the reduced neovascularization capacity of endothelial progenitor cells from patients with coronary artery disease. Circ Res 97(11): 1142–1151.
- Wrana JL. 2000; Regulation of Smad activity. Cell 100(2): 189–192.
- Wu X, Rabkin-Aikawa E, Guleserian KJ, et al. 2004; Tissue-engineered microvessels on three-dimensional biodegradable scaffolds using human endothelial progenitor cells. Am J Physiol Heart Circ Physiol 287(2): H480–487.
- Yoon CH, Hur J, Park KW, et al. 2005; Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases. Circulation 112(11): 1618–1627.
- Young PP, Vaughan DE, Hatzopoulos AK. 2007; Biologic properties of endothelial progenitor cells and their potential for cell therapy. Prog Cardiovasc Dis 49(6): 421–429.
